Workers at a South Korean automobile battery manufacturing plant were allegedly given injections intended to remove heavy metals from their bodies while being told they were receiving vitamins. President Lee Jae-myung has ordered a government investigation into the reported practice, calling it a serious potential violation of workers' rights and safety. His October 12 instruction followed reports that lead levels detected during production exceeded the permitted standard by more than five times, yet the workplace passed an assessment of its working environment. The discrepancy is now at the centre of questions about whether exposure was deliberately concealed.
The account released by the presidential office describes a troubling sequence. Instead of addressing the source of hazardous exposure, the company allegedly administered repeated injections that were presented to employees as routine vitamin treatment. Such an intervention, if established, would make the workplace appear safer on paper without necessarily making the manufacturing process safer. The central allegation is not merely that a factory had excessive lead readings. It is that a method of medical treatment may have been used to interfere with the very safeguards intended to detect dangerous exposure.
- Official response
- Presidential investigation order, October 12
- Reported lead levels
- More than five times the standard
- Status
- Allegations under investigation
Lee requested reports from the Ministry of Employment and Labor on measures already taken and the next steps. He instructed labour authorities and investigators to establish how much hazardous material workers encountered, how and why the injections were administered, and whether health screening results were hidden. The president also directed officials to take action under the law if violations are found. The investigation remains necessary because a presidential statement about reported conduct is not itself a finding of criminal liability against the employer or individual managers.
The danger of measuring around the hazard
The medical and regulatory issues intersect. Industrial health assessments are meant to identify dangerous conditions and trigger controls that protect people while they work. Treating individual workers, especially without transparent disclosure of the nature and purpose of an injection, cannot substitute for reducing contamination at its source. The reported practice would invert that relationship: a health intervention would serve the appearance of compliance rather than employees' informed care. Authorities will need to determine the clinical substance involved, what workers were told, and what the employer knew.
The presidential briefing did not give a confirmed number of affected workers, verified medical outcomes or a completed account of the factory's actions. It also did not establish whether injections directly altered the assessment results. Those distinctions matter because several different types of misconduct could be at issue, including workplace exposure, consent to treatment and the integrity of occupational health records. Each requires evidence rather than inference. The most immediate responsibility for investigators is to reconstruct the actual work conditions, testing chronology and individual treatment histories.
Lee called on officials to examine whether other workplaces may be using similar techniques to undermine industrial safety arrangements. That widens the policy significance beyond the facility named in the reports. Employers across hazardous industries depend on measurements and medical surveillance to detect risks that employees cannot see. If those systems can be manipulated, routine compliance records may offer false reassurance to workers, regulators and nearby communities. A wider check would need to focus on suspicious discrepancies between production measurements, health checks and reported worker treatment.
The questions investigators must settle
For affected employees, the outcome will be measured less by the prominence of the presidential order than by access to reliable exposure records, clear medical explanations and protective measures at the plant. Workers should be able to understand what substances they handled and any treatment they received. Independent verification of exposure is also essential before conclusions are drawn about individual health effects. A genuinely protective response would address the industrial process and any deficiencies in monitoring, not simply review how its results were recorded.
The next official findings will need to answer three concrete questions: whether lead exposure exceeded the relevant limits, whether injections were repeatedly administered under a misleading description, and whether any assessments or health records were knowingly distorted. Investigators must also determine who authorized the actions and whether employees were informed. Until those findings emerge, the injections and concealment remain allegations. The established development is that the president has ordered an investigation and demanded legal accountability if the suspicions are substantiated.